Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
19.00
+0.25 (1.33%)
Mar 10, 2026, 3:00 PM CST
-17.57%
Market Cap 7.86B
Revenue (ttm) 591.81M
Net Income (ttm) -272.07M
Shares Out 413.66M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend 0.17 (0.90%)
Ex-Dividend Date Jun 18, 2025
Volume 1,562,323
Average Volume 1,793,181
Open 18.81
Previous Close 18.75
Day's Range 18.81 - 19.04
52-Week Range 18.44 - 26.30
Beta 0.05
RSI 40.80
Earnings Date Mar 12, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.